This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James C. Dearth, MD; Richard B. Tompkins, MD; Emilio R. Giuliani, MD; Robert H. Feldt, MD

Am J Dis Child. 1978;132(9):900-902.

Abstract
β Gout is rarely noted as a clinical problem in secondary polycythemia—even if profound polycythemia exists, as in cyanotic congenital heart disease. A retrospective study of 81 patients with congenital heart disease was done to assess the incidence of hyperuricemia. Twenty of 46 patients with cyanotic congenital heart disease had serum levels of uric acid greater than 8 mg/dl. Thirteen of 16 (81%) cyanotic male patients more than 15 years old had serum levels greater than 8 mg/dl. For cyanotic patients, serum levels of uric acid were related directly to the degree of polycythemia (r =.44; P <.02). Impaired renal function or drug therapy did not seem to account for the hyperuricemia. Because levels of uric acid greater than 10 mg/dl probably are nephropathic, many of these patients may be incurring subclinical uric acid nephropathy.

(Am J Dis Child 132:900-902, 1978)

Author Affiliations
Fom the Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Reprint requests to Section of Publications, Mayo Clinic, 200 First St SW, Rochester, MN 55901 (Dr Dearth).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The management of hyperuricemia and gout in patients with heart failure
Spieker et al.
Eur J Heart Fail 2002;4:403-410.
FULL TEXT  

Hyperuricemia in Severe Pulmonary Hypertension*
Voelkel et al.
Chest 2000;117:19-24.
ABSTRACT | FULL TEXT